A new protocol for differentiating human embryonic stem cells to RPE cells could be a safe and effective approach for treating age-related macular degeneration.
A new protocol for differentiating human embryonic stem cells to RPE cells could be a safe and effective approach for treating age-related macular degeneration.
Share this Article
Recommended